• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单细胞测序在免疫治疗中的应用。

Application of Single-Cell Sequencing to Immunotherapy.

机构信息

Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, 1425 Madison Avenue, Box 1498, New York, NY 10029, USA.

Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, 1425 Madison Avenue, Box 1498, New York, NY 10029, USA.

出版信息

Urol Clin North Am. 2020 Nov;47(4):475-485. doi: 10.1016/j.ucl.2020.07.005. Epub 2020 Sep 9.

DOI:10.1016/j.ucl.2020.07.005
PMID:33008498
Abstract

Cancer is a highly complex and heterogeneous disease and immunotherapy has shown promise as a therapeutic approach. The increased resolution afforded by single-cell analysis offers the hope of finding and characterizing previously underappreciated populations of cells that could prove useful in understanding cancer progression and treatment. Urologic and prostate cancers are inherently heterogeneous diseases, and the potential for single-cell analysis to help understand and develop immunotherapeutic approaches to treat these diseases is very exciting. In this review, we view cancer immunotherapy through a single-cell lens and discuss the state-of-the-art technologies that enable advances in this field.

摘要

癌症是一种高度复杂和异质的疾病,免疫疗法已显示出作为一种治疗方法的前景。单细胞分析提供的更高分辨率有望发现和描述以前未被充分认识的细胞群体,这可能有助于理解癌症的进展和治疗。泌尿系统和前列腺癌是固有异质性疾病,单细胞分析有可能帮助理解和开发免疫治疗方法来治疗这些疾病,这非常令人兴奋。在这篇综述中,我们从单细胞的角度来看待癌症免疫疗法,并讨论了推动该领域发展的最先进技术。

相似文献

1
Application of Single-Cell Sequencing to Immunotherapy.单细胞测序在免疫治疗中的应用。
Urol Clin North Am. 2020 Nov;47(4):475-485. doi: 10.1016/j.ucl.2020.07.005. Epub 2020 Sep 9.
2
Immunotherapy for Metastatic Prostate Cancer: Current and Emerging Treatment Options.免疫疗法治疗转移性前列腺癌:当前和新兴的治疗选择。
Urol Clin North Am. 2020 Nov;47(4):487-510. doi: 10.1016/j.ucl.2020.07.010. Epub 2020 Sep 28.
3
Immunotherapy for triple-negative breast cancer: Existing challenges and exciting prospects.三阴性乳腺癌的免疫治疗:现存挑战与振奋前景。
Drug Resist Updat. 2017 May;32:1-15. doi: 10.1016/j.drup.2017.07.002. Epub 2017 Aug 19.
4
A Systematic Review of Immunotherapy in Urologic Cancer: Evolving Roles for Targeting of CTLA-4, PD-1/PD-L1, and HLA-G.免疫疗法在泌尿系统肿瘤中的系统评价:CTLA-4、PD-1/PD-L1 和 HLA-G 靶向作用的不断演变。
Eur Urol. 2015 Aug;68(2):267-79. doi: 10.1016/j.eururo.2015.02.032. Epub 2015 Mar 29.
5
Prostate cancer immunotherapy: where are we and where are we going?前列腺癌免疫疗法:我们目前的状况与未来的发展方向?
Curr Opin Urol. 2018 Jan;28(1):15-24. doi: 10.1097/MOU.0000000000000462.
6
Cancer immunotherapy: A paradigm shift in the treatment of advanced urologic cancers.癌症免疫疗法:晚期泌尿系统癌症治疗中的范式转变。
Urol Oncol. 2017 Dec;35(12):676-677. doi: 10.1016/j.urolonc.2017.09.023. Epub 2017 Oct 18.
7
The Emergence of Precision Urologic Oncology: A Collaborative Review on Biomarker-driven Therapeutics.精准泌尿外科肿瘤学的兴起:关于生物标志物驱动治疗的协作性综述
Eur Urol. 2017 Feb;71(2):237-246. doi: 10.1016/j.eururo.2016.08.024. Epub 2016 Aug 25.
8
Overcoming Oncogenic Mediated Tumor Immunity in Prostate Cancer.克服前列腺癌中致癌介导的肿瘤免疫
Int J Mol Sci. 2017 Jul 17;18(7):1542. doi: 10.3390/ijms18071542.
9
[Optimizing treatment of advanced urologic malignancies].[优化晚期泌尿系统恶性肿瘤的治疗]
Urologe A. 2007 Sep;46(9):1278-84. doi: 10.1007/s00120-007-1396-4.
10
Immunotherapy for osteosarcoma: Where do we go from here?骨肉瘤的免疫治疗:我们的路在何方?
Pediatr Blood Cancer. 2018 Sep;65(9):e27227. doi: 10.1002/pbc.27227. Epub 2018 Jun 19.

引用本文的文献

1
Exploring the Prognostic Significance and Immunotherapeutic Potential of Single-Cell Sequencing-Identified Long Noncoding RNA (LncRNA) in Patients With Non-small Cell Lung Cancer.探索单细胞测序鉴定的长链非编码RNA(LncRNA)在非小细胞肺癌患者中的预后意义及免疫治疗潜力。
Cureus. 2023 Nov 7;15(11):e48436. doi: 10.7759/cureus.48436. eCollection 2023 Nov.
2
Immunotherapy in Genitourinary Malignancy: Evolution in Revolution or Revolution in Evolution.泌尿生殖系统恶性肿瘤的免疫治疗:是变革中的演进还是演进中的变革。
Cancer Treat Res. 2022;183:201-223. doi: 10.1007/978-3-030-96376-7_7.
3
Deciphering the Immune-Tumor Interplay During Early-Stage Lung Cancer Development Single-Cell Technology.
解析早期肺癌发展过程中的免疫-肿瘤相互作用 单细胞技术
Front Oncol. 2022 Jan 3;11:716042. doi: 10.3389/fonc.2021.716042. eCollection 2021.